AZN
AstraZeneca PLC
Stock
$156.90−0.80 (−0.51%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $719M
- YoY, 2025
- +8.9%
- 5-year CAGR
- +21.0%
- 10-year CAGR
- +13.0%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $719M | +8.9% |
| 2024 | $660M | +14.0% |
| 2023 | $579M | −6.5% |
| 2022 | $619M | +0.7% |
| 2021 | $615M | +122.0% |
| 2020 | $277M | +6.9% |
| 2019 | $259M | +18.3% |
| 2018 | $219M | −0.5% |
| 2017 | $220M | −8.7% |
| 2016 | $241M | +14.2% |
| 2015 | $211M | — |